Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta‐Analysis

Abstract

Objective. To evaluate the efficacy and safety of large dosage of Chishao in formulae for treatment of cholestatic hepatitis. Methods. The major databases (PubMed, Embase, Cochrane Library, Chinese Biomedical Database Wanfang, VIP medicine information system, and China National Knowledge Infrastructure) were searched until January 2014. Randomized controlled trials (RCTs) of large dosage of Chishao in formulae that reported on publications in treatment of cholestatic hepatitis with total efficacy rate, together with the biochemical indices including alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and direct bilirubin (DBIL), were extracted by two reviewers. The Cochrane tool was used for the assessment of risk of bias included trials. Data were analyzed with RevMan 5.2.7 software. Results. 11 RCTs involving 1275 subjects with cholestatic hepatitis were included. Compared with essential therapy, large dosage of Chishao in formulae demonstrated more efficiently with down regulation of serum ALT, AST, TBIL, DBIL. Meanwhile, there were no obvious adverse events. Conclusion. As a promising novel treatment approach, widely using large dosage of Chishao in formulae may enhance the curative efficacy for cholestatic hepatitis. Considering being accepted by more and more practitioners, further rigorously designed clinical studies are required.

Dioscin Protects ANIT-Induced Intrahepatic Cholestasis Through Regulating Transporters, Apoptosis and Oxidative Stress

“…Accumulating event suggests that free radicals are associated with apoptosis and lipid peroxidation in cholestatic lesions (Yang et al, 2009), and we believe that OS is a key factor for cholestatic damage (Ma et al, 2014). ANIT, a commonly used hepatotoxicant, can interrupt bile flow and accumulate bile acids in liver (Ohta et al, 1999).…”

Paeonia lactiflora Pall. regulates the NF-κB-NLRP3 inflammasome pathway to alleviate cholestasis in rats

“…Therefore, in this study, rats with ANIT treatment were applied to mimic the cholestasis and explore the potential mechanism of cholestatic hepatitis. Previous studies showed PLP exhibited multiple pharmacological effects, such as liver protection, anti‐oxidation, anti‐allergic, vasodilatation of thoracic aorta and immune‐regulation effects . Recent studies have highlighted that PLP exerts its pharmacological effects via anti‐inflammation effect .…”

“…In the United States, cholestasis is in the top 15 leading causes of death based on the statistics data from the Centers for Disease Control . In addition to these, cholestasis produces heavy patient and societal burdens in China . It is the condition that bile cannot flow from liver to duodenum, characterized by the reduction in bile flow and the excessive accumulation of bile acid as well as any other toxic compounds .…”

Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway

“…Paeoniflorin, a monoterpene glycoside, is one of the main bioactive components in Paeonia lactiflora Pall or Paeonia veitchii Lynch, which have been used for more than 2000 years in traditional Chinese medicine [16]. Paeoniflorin has been consistently shown to exhibit multiple pharmacological effects in liver disease [17].…”